Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-061406
Filing Date
2012-11-30
Accepted
2012-11-30 16:55:38
Documents
1
Period of Report
2012-11-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd361917.html 4  
1 FORM 4 rrd361917.xml 4 7709
  Complete submission text file 0001181431-12-061406.txt   9028
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7501 WISCONSIN AVENUE SUITE 600E BETHESDA MD 20814
Business Address
Kuno Sachiko (Reporting) CIK: 0001383384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 121235255